[SaneVax: Five different countries have one thing in common: multiple child deaths after the administration of a new pentavalent vaccine. Does this mean the new combination DPT, HiB, Hep B vaccine will be pulled from the market until the vaccine is ruled out as a possible cause of death? In the interest of public health and safety, there should be no other alternative.]
Pentavalent vaccine killing children in India, Vietnam
By J.D. Heyes
(NaturalNews) A group of academics, professors, public health teachers and pediatricians concerned about deaths following the administration of the Pentavalent vaccine is requesting that health officials have it withdrawn from the vaccination schedule in India.
The vaccine, which is a combination of DPT, Hib and Hep B, was recently introduced in the states of Kerala and Tamil Nadu, in southern India, following a recommendation by the National Technical Advisory Group on Immunization, according to the Office of Medical and Scientific Justice, a private investigative agency specializing in “victims and witnesses of medical and scientific corruption.”
In a letter to national health officials, the group said there had been concern over the safety of the vaccine, so it was only introduced in two states, in order to monitor its safety.
No ‘alternative cause’ found
“Thereafter, according to the minutes of the NTAGI meeting, the data was to be reviewed after one year of the introduction, before extending its use to other states. We are concerned that well before the data from Kerala and Tamil Nadu could be analyzed, it was introduced in Haryana at the end of last year,” said the letter, which was sent to the Indian health secretary on Jan. 15.
The group said that three more infants had died in Kerala recently, while another died in Haryana, all after being given the vaccine. At first glance, there seems to be no “alternative cause” for the deaths other than the vaccine, it said.
In November, there were three deaths in Vietnam, which led health officials there to terminate use of the vaccine immediately. There have been similar related deaths in Sri Lanka, Bhutan and Pakistan after administration of the vaccine.
S Johar says
There has been a debate in the electronic BMJ with the Managing Director of Serum Institute that makes this vaccine.
The discussion helps throw light on some aspects that are not understood by the lay public – especially about cause and effect relationship between vaccine and death. Readers may find the eBMJ links informative
Addendum to response of author
http://www.bmj.com/content/341/bmj.c4001/rr/630682
The Director Serum Institute wrote originally:
http://www.bmj.com/content/341/bmj.c4001/rr/628472
This response has been published
http://www.bmj.com/content/341/bmj.c4001/rr/629317
Later Peter Flegg responded to the response.
It can be viewed here.
http://www.bmj.com/content/341/bmj.c4001/rr/629524
The response is available here
http://www.bmj.com/content/341/bmj.c4001/rr/629565
admin says
Thank you for providing both sides of the story. This needs to happen much more frequently – particularly in regard to vaccines and the typical promotion of the one-size-fits-all vaccination programs that are so common.